|
PD184161
|
5-溴-2-((2-氯-4-碘苯基)氨基)-N-(环丙基甲氧基)-3,4-二氟苯甲酰胺
|
212631-67-9
|
|
Fustin
|
黄颜木素
|
20725-03-5
|
|
L-Moses
|
2079885-05-3
|
2079885-05-3
|
|
KEA1-97
|
KEA1-97
|
2138882-71-8
|
|
HTH-01-091
|
化合物 T24152
|
2000209-42-5
|
|
AP1867-3-(aminoethoxy)
|
AP1867-3-(Methoxyethylamine)
|
2127390-15-0
|
|
CA inhibitor 1
|
CA INHIBITOR 1
|
2189684-45-3
|
|
PKUMDL-LC-101-D04
|
PKUMDL-LC-101-D04
|
2143896-83-5
|
|
Eclitasertib
|
ECLITASERTIB
|
2125450-76-0
|
|
Capsiate
|
辣椒素酯
|
205687-01-0
|
|
BMS 753
|
4-[[(2,3-Dihydro-1,1,3,3-tetramethyl-2-oxo-1H-inden-5-yl)carbonyl]amino]-benzoic acid
|
215307-86-1
|
|
PDGFR Tyrosine Kinase Inhibitor III
|
PDGFR酪氨酸激酶抑制剂III
|
205254-94-0
|
|
AZ13705339 hemihydrate
|
化合物 T26704
|
2016806-57-6
|
|
SMYD3-IN-1
|
SMYD3-IN-1
|
2095160-79-3
|
|
RAD51-IN-1
|
RAD51-IN-17
|
2101739-18-6
|
|
IACS-13909
|
4-Piperidinamine, 1-[3-(2,3-dichlorophenyl)-1H-pyrazolo[3,4-b]pyrazin-6-yl]-4-methyl-
|
2160546-07-4
|
|
Bocidelpar
|
化合物BOCIDELPAR
|
2095128-20-2
|
|
RORγt inverse agonist 13
|
化合物RORΓT INVERSE AGONIST 13
|
2170477-75-3
|
|
Enpatoran
|
化合物ENPATORAN
|
2101938-42-3
|
|
LY392098
|
化合物 T27951
|
211311-39-6
|
|
SGC-SMARCA-BRDVIII
|
化合物SGC-SMARCA-BRDVIII
|
1997319-84-2
|
|
Enpatoran hydrochloride
|
|
2101945-93-9
|
|
GNE-064
|
化合物GNE-064
|
1997321-20-6
|
|
Edaglitazone
|
依格列宗
|
213411-83-7
|
|
Laninamivir octanoate
|
辛酸拉尼米韦
|
203120-46-1
|
|
MS-PPOH
|
MS-PPOH
|
206052-02-0
|
|
SB-273005
|
SB273005 INTEGRIN抑制剂
|
205678-31-5
|
|
2'-O-Methylguanosine
|
2'-甲氧基鸟苷
|
2140-71-8
|
|
GSK8814
|
GSK8814
|
1997369-78-4
|
|
LTβR-IN-1
|
Compound 919278
|
2189366-77-4
|
|
Rilmenidine phosphate
|
化合物BU 224 HYDROCHLORIDE
|
205437-64-5
|
|
2BAct
|
2BAct(eIF2B activator 2BAct)
|
2143542-28-1
|
|
Parsaclisib hydrochloride
|
PARSACLISIB HYDROCHLORIDE
|
1995889-48-9
|
|
TP-021
|
BCL6 inhibitor 8c
|
2130878-25-8
|
|
Cedirogant
|
4-Piperidineacetic acid, 1-[2,4-dichloro-3-[[7-chloro-5-(trifluoromethyl)-1H-indol-1-yl]methyl]benzoyl]-
|
2055496-11-0
|
|
MAGL-IN-4
|
His121 ARG57
|
2135785-20-3
|
|
GSK-3685032
|
GSK 3685032
|
2170137-61-6
|
|
Rimtuzalcap
|
化合物RIMTUZALCAP
|
2167246-24-2
|
|
FASN-IN-3
|
FASN inhibitor 1
|
2097262-60-5
|
|
Atuliflapon
|
AZD5718
|
2041075-86-7
|
|
PHD-1-IN-1
|
化合物PHD-1-IN-1
|
2009343-14-8
|
|
PPOH
|
2-(2-PROPYNYLOXY)-BENZENEHEXANOIC ACID
|
206052-01-9
|
|
ASN007
|
ASN007; ASN-007; ASN 007;
|
2055597-12-9
|
|
Secnidazole-d
|
7-Benzofurancarboxylic acid, 6-fluoro-, ethyl ester
|
2114651-20-4
|
|
Pirtobrutinib
|
LOXO-305
|
2101700-15-4
|
|
NHWD-870
|
化合物NHWD-870
|
2115742-03-3
|
|
Vociprotafib
|
RMC-4630
|
2172652-48-9
|
|
Vepafestinib
|
维利帕尼
|
2129515-96-2
|
|
Fanotaprim
|
化合物FANOTAPRIM
|
2120282-75-7
|
|
α5IA
|
3-(5-甲基-3-异噁唑基)-6-[(1-甲基-1H-1,2,3-三氮唑-4-基)甲氧基][1,2,4]三氮唑并[3,4-A]酞嗪
|
215874-86-5
|
|
NSC 617145
|
NSC617145
|
203115-63-3
|
|
RIP1 kinase inhibitor 1
|
RIP1 KINASE INHIBITOR 1
|
2095515-38-9
|
|
Spiraeoside
|
绣线菊甙
|
20229-56-5
|
|
Lisaftoclax
|
Bcl-2/Bcl-xl inhibitor 1
|
2180923-05-9
|
|
(Rac)-X77
|
X77 rac
|
2144491-78-9
|
|
GSK620
|
GSK620
|
2088410-46-0
|
|
Tovinontrine
|
TOVINONTRINE
|
2062661-53-2
|
|
Cevidoplenib dimesylate
|
CEVIDOPLENIB (DIMESYLATE)
|
2043659-93-2
|
|
FLT3-IN-10
|
化合物FLT3-IN-10
|
2088735-51-5
|
|
BIRT 377
|
BIRT 377
|
213211-10-0
|
|
AOH1160
|
AOH1160
|
2089314-57-6
|
|
Diprovocim
|
Diprovocim
|
2170867-89-5
|
|
PXS-5120A
|
PXS-5120A
|
2125955-70-4
|
|
VTP50469 fumarate
|
化合物 T13336L
|
2169919-29-1
|
|
HCV-IN-31
|
Adenosine, 2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-, (2'R)-
|
1998705-62-6
|
|
Picroside IV
|
胡黄连苷IV
|
211567-04-3
|
|
2′,7′-Dichlorofluorescein diacetate
|
双氯荧光黄乙酸乙酯
|
2044-85-1
|
|
ALX-5407 hydrochloride
|
N-[(3R)-3-([1,1'-联苯]-4-基氧)-3-(4-氟苯基)丙基]-N-甲基甘氨酸盐酸盐
|
200006-08-2
|
|
TRAM-39
|
化合物 T23471
|
197525-99-8
|
|
P-gp inhibitor 1
|
P-GP INHIBITOR 1
|
2050747-49-2
|
|
MLT-747
|
MLT-747
|
2097853-86-4
|
|
SERCA2a activator 1
|
SERCA2a activator A
|
2139330-34-8
|
|
Reuterin
|
罗氏菌素
|
2134-29-4
|
|
Et-29
|
化合物ET-29
|
2166487-23-4
|
|
NLG802
|
化合物NLG802
|
2071683-99-1
|
|
Imatinib-d
|
化合物CT52923
|
205256-55-9
|
|
Gly-Phe-β-naphthylamide
|
(S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺
|
21438-66-4
|
|
Teduglutide
|
替度鲁肽
|
197922-42-2
|
|
Ro 3-1314
|
9,12-OCTADECADIYNOIC ACID
|
2012-14-8
|
|
JNJ-55308942
|
JNJ-55308942
(JNJ55308942)
|
2166558-11-6
|
|
SHP394
|
SHP394
|
2055757-40-7
|
|
ENMD-1198
|
|
2097938-74-2
|
|
NV-5138
|
Pentanoic acid, 2-amino-5,5-difluoro-4,4-dimethyl-, (2S)-
|
2095886-80-7
|
|
TRPM8 antagonist 3
|
化合物TRPM8 ANTAGONIST 3
|
2102179-29-1
|
|
Inarigivir ammonium
|
INARIGIVIR铵
|
2172788-92-8
|
|
4-PPBP maleate
|
化合物 T22513
|
201216-39-9
|
|
OBI-3424
|
OBI-3424
|
2097713-68-1
|
|
S18-000003
|
Benzeneacetamide, N-(2,4-difluorophenyl)-4-[[2-[4-(ethylsulfonyl)phenyl]acetyl]amino]-2-fluoro-α,α-dimethyl-
|
2068119-11-7
|
|
SRI-29329
|
化合物SRI-29329
|
2086809-58-5
|
|
Bemnifosbuvir
|
L-Alanine, N-[[P(S),2'R]-2-amino-2'-deoxy-2'-fluoro-N,2'-dimethyl-P-phenyl-5'-adenylyl]-, 1-methylethyl ester
|
1998705-64-8
|
|
ML-211
|
化合物ML-211
|
2205032-89-7
|
|
Oritinib
|
化合物ORITINIB
|
2035089-28-0
|
|
Glycine-2-
|
甘氨酸-2-13C
|
20220-62-6
|
|
Methylene blue hydrate
|
L-精氨酸-13C6 盐酸盐
|
201740-91-2
|
|
Vebicorvir
|
ABI-H0731
|
2090064-66-5
|
|
BMS-1166 hydrochloride
|
BMS-1166 HCl
|
2113650-05-6
|
|
USP30 inhibitor 11
|
(S)-1-cyano-N-(4-(6-cyano-5-methoxypyridin-2-yl)thiazol-2-yl)-N-methylpyrrolidine-2-carboxamide
|
2067332-64-1
|
|
GENZ-882706
|
2070864-35-4
|
2070864-35-4
|
|
AT-130
|
AT-130
(AT130)
|
211364-06-6
|
|
KDM2A/7A-IN-1
|
KDM2A/7A-IN-1
|
2169272-46-0
|